ALBERS JEFFREY W. sold 71.1% of their position (23K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.40M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/11/2026ACC: 0001636282-26-000102
Director
Since Nov 2023
-23K
Net shares
Net seller
$2.40M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
5K acquired · 28K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5K
Price / share
$10.39
Trade value
$51.95K
% of position
New position
8/7/2026
0.00→5K
Common Stock
Direct
Shares
−5K
Price / share
$104.47
Trade value
$522.35K
% of position
New position
8/7/2026
5K→0.00
Common Stock
Indirect
Shares
−8K
Price / share
$104.38
Trade value
$835.04K
% of position
29.2%
8/7/2026
27.36K→19.36K
Common Stock
Indirect
Shares
−10K
Price / share
$104.68
Trade value
$1.05M
% of position
51.7%
8/7/2026
19.36K→9.36K
Total
Net shares
−18K
Net value
-$2.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2026 | M · Option Exercise | +5K | $10.39 | $51.95K | New position | 0.00 | 5K |
| Common Stock Direct | 8/7/2026 | S · Sale | −5K | $104.47 | $522.35K | New position | 5K | 0.00 |
| Common Stock Indirect | 8/7/2026 | S · Sale | −8K | $104.38 | $835.04K | 29.2% | 27.36K | 19.36K |
| Common Stock Indirect | 8/7/2026 | S · Sale | −10K | $104.68 | $1.05M | 51.7% | 19.36K | 9.36K |
| Total | −18K | -$2.35M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
10.39
Held after
45K
Exercisable
—
8/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 8/7/2026 | M · Option Exercise | −5K | 10.39 | — | 45K |